<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<meta property="og:title" content="Global response to antimicrobial resistance |    97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
<meta property="og:type" content="book" />





<meta name="author" content="Russell E. Lewis, Associate Professor, Infectious Diseases, University of Bologna" />


<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  TeX: { equationNumbers: { autoNumber: "AMS" } }
});
</script>
  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

<meta name="description" content="Global response to antimicrobial resistance |    97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES">

<title>Global response to antimicrobial resistance |    97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</title>

<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="libs/bootstrap-3.3.5/css/bootstrap.min.css" rel="stylesheet" />
<script src="libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="libs/navigation-1.1/tabsets.js"></script>




<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="toc.css" type="text/css" />

<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
/* show arrow before summary tag as in bootstrap
TODO: remove if boostrap in updated in html_document (rmarkdown#1485) */
details > summary {
  display: list-item;
  cursor: pointer;
}
</style>
</head>

<body>

<div class="container-fluid main-container">


<div class="row">
<div class="col-sm-12">
<div id="TOC">
<ul>
<li><a href="a-brief-history-of-antimicrobial-resistance-amr.html#a-brief-history-of-antimicrobial-resistance-amr">A brief history of antimicrobial resistance (AMR)</a></li>
<li><a href="global-response-to-antimicrobial-resistance.html#global-response-to-antimicrobial-resistance">Global response to antimicrobial resistance</a></li>
<li><a href="what-are-the-drivers-of-antimicrobial-resistance.html#what-are-the-drivers-of-antimicrobial-resistance">What are the drivers of antimicrobial resistance?</a></li>
<li><a href="amr-in-low-middle-income-countries-lmics.html#amr-in-low-middle-income-countries-lmics">AMR in Low-Middle Income Countries (LMICs)</a>
<ul>
<li><a href="amr-in-low-middle-income-countries-lmics.html#how-can-the-effectiveness-of-antimicrobials-be-preserved">How can the effectiveness of antimicrobials be preserved?</a></li>
<li><a href="amr-in-low-middle-income-countries-lmics.html#case-study-a-successful-national-antibiotic-stewardship-program-in-a-lmic">Case study: A successful national antibiotic stewardship program in a LMIC</a></li>
</ul></li>
<li><a href="amr-situation-in-italy.html#amr-situation-in-italy">AMR situation in Italy</a></li>
<li><a href="the-global-future-of-amr.html#the-global-future-of-amr">The global future of AMR</a></li>
<li><a href="one-health-perspective-of-amr.html#one-health-perspective-of-amr">One-Health Perspective of AMR</a>
<ul>
<li><a href="one-health-perspective-of-amr.html#antibiotic-use-in-animal-food-production">Antibiotic use in animal food production</a></li>
<li><a href="one-health-perspective-of-amr.html#the-impact-of-animal-antibiotic-use-on-human-amr">The impact of animal antibiotic use on human AMR</a></li>
<li><a href="one-health-perspective-of-amr.html#antimicrobial-resistance-in-animals-in-lmics">Antimicrobial resistance in animals in LMICs</a></li>
<li><a href="one-health-perspective-of-amr.html#environmental-concerns">Environmental concerns</a></li>
</ul></li>
<li><a href="cross-border-spread-of-amr.html#cross-border-spread-of-amr">Cross-border spread of AMR</a></li>
<li><a href="summary.html#summary">Summary</a></li>
<li><a href="lecture-slides.html#lecture-slides">Lecture Slides</a></li>
<li><a href="references.html#references">References</a></li>
</ul>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12">
<div id="global-response-to-antimicrobial-resistance" class="section level2 unnumbered">
<h2>Global response to antimicrobial resistance</h2>
<p>Recognizing the growing global threat of antibiotic resistance (AMR) on human health but also the economy and human development, The World Health Organization (WHO) and The Organisation for Animal Health (OIE) developed in 2001 a Global Plan for Containment of Antimicrobial Resistance that subsequently led to a <a href="https://www.who.int/publications/i/item/9789241509763">Global Action Plan for AMR</a> in 2017 and more recently a <a href="https://www.who.int/news/item/30-07-2021-call-to-action-on-antimicrobial-resistance-2021">“Call to Action on Antimicrobial Resistance”</a> in 2021. The plan outlines 21 strategies and 5 strategic objectives action plans that should be implemented in member states to address AMR. These include:</p>
<ol style="list-style-type: decimal">
<li>Improvements in the awareness and understanding of antimicrobial resistance through effective communication, education and training</li>
<li>Strengthening of knowledge and evidence base of AMR through surveillance and research</li>
<li>Reductions in the incidence of infection through effective sanitation, hygiene and infection prevention measures</li>
<li>Optimization the use of antimicrobial medicines in human and animal health</li>
<li>Development of an economic case for sustainable investment in AMR research that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions</li>
</ol>
<p>The WHO also proposed a <a href="https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf">Priority Pathogen List</a> for research and development of new antibiotics and established a global antimicrobial use and surveillance program. This list includes bacterial pathogens that are considered to be be the biggest threat to human health in addition to <em>Mycobacterium tuberculosis.</em> The WHO list breaks down pathogens into three groups:</p>
<figure>
<figcaption>
<p><strong>Table 1. WHO priority pathogens</strong></p>
</figcaption>
<table>
<colgroup>
<col width="13%" />
<col width="86%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Priority</th>
<th align="left">Pathogens included</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left"><strong>Critical</strong></td>
<td align="left"><p><em>Acinetobacter baumannii</em> (Carbapenem-resistant)</p>
<p><em>Pseudomonas aeruginosa</em> (Carbapenem-resistant)</p>
<p>Enterbacterales (3rd generation cephalosporin, carbapenem-resistant)</p></td>
</tr>
<tr class="even">
<td align="left"><strong>High</strong></td>
<td align="left"><p><em>Enterococcus faecium</em>, vancomycin-resistant</p>
<p><em>Staphylococcus aureus</em>, methicillin-resistant, vancomycin intermediate and resistant</p>
<p><em>Helicobacter pylori</em>, clarithromycin-resistant</p>
<p><em>Campylobacter</em>, fluoroquinolone-resistant</p>
<p><em>Salmonella</em> spp., fluoroquinolone-resistant</p>
<p><em>Neisseria gonorrhoeae</em>, 3rd generation cephalosporin-resistant, fluoroquinolone-resistant</p></td>
</tr>
<tr class="odd">
<td align="left"><strong>Medium</strong></td>
<td align="left"><p><em>Streptococcus pneumoniae</em>, penicillin-non-susceptible</p>
<p><em>Haemophilus influenzae</em>, ampicillin-resistant</p>
<p><em>Shigella</em> spp., fluoroquinolone-resistant</p></td>
</tr>
</tbody>
</table>
</figure>
<p>These pathogens may exhibit multi-drug resistance (MDR), extensive drug resistance (XDR) or pan-drug resistance (PDR).<span class="citation"><sup>2</sup></span> Difficult-to-treat resistance (DTR) is a newer definition used to define isolate resistance patterns that require the use of less-effective or more toxic “reserve” antibiotics- e.g., <em>Acinetobacter baumanii</em> susceptible only to colistin and tobramycin.<span class="citation"><sup>3</sup></span></p>
<style>
div.blue { background-color:#e6f0ff; border-radius: 5px; padding: 20px;}
</style>
<div class="blue">
<p>MDR- resistance to one agent in at least 3 antibiotic categories; XDR- resistant except to 2 or fewer antibiotic categories; PDR- resistant to all agents in all antibiotic categories; DTR-requires the use of less-effective or more toxic “reserve” antibiotics</p>
</div>
<p><br>Currently, both the <a href="https://apps.who.int/iris/bitstream/handle/10665/312266/9789241515528-eng.pdf">WHO</a> and <a href="https://www.oie.int/en/what-we-do/global-initiatives/antimicrobial-resistance/#ui-id-4">OIE</a> have also developed lists of antibiotics that are considered of “critical importance” for human and animal medicine. These lists help establish priorities for antimicrobial resistance surveillance and new drug development.</p>
</div>
<p style="text-align: center;">
<a href="a-brief-history-of-antimicrobial-resistance-amr.html"><button class="btn btn-default">Previous</button></a>
<a href="what-are-the-drivers-of-antimicrobial-resistance.html"><button class="btn btn-default">Next</button></a>
</p>
</div>
</div>


</div>

<script>

// add bootstrap table styles to pandoc tables
$(document).ready(function () {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
});

</script>

</body>
</html>
